These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4120768)

  • 1. Sustained-release levodopa in Parkinsonism.
    Curzon G; Friedel J; Grier L; Marsden CD; Parkes JD; Shipley M; Zilkha KJ
    Lancet; 1973 Apr; 1(7806):781. PubMed ID: 4120768
    [No Abstract]   [Full Text] [Related]  

  • 2. Sustained-release levodopa.
    Woods AC; Glaubiger GA; Chase TN
    Lancet; 1973 Jun; 1(7816):1391. PubMed ID: 4122780
    [No Abstract]   [Full Text] [Related]  

  • 3. Slowly absorbed L-dopa preparation in the treatment of parkinsonism.
    Laitinen LV
    Acta Neurol Scand; 1973; 49(3):331-8. PubMed ID: 4747020
    [No Abstract]   [Full Text] [Related]  

  • 4. Sustained-release levodopa in parkinsonism.
    Eckstein B; Shaw K; Stern G
    Lancet; 1973 Feb; 1(7800):431-2. PubMed ID: 4119747
    [No Abstract]   [Full Text] [Related]  

  • 5. Levodopa and orphenadrine hydrochloride in Parkinsonism.
    Whyte RK; Hunter KR; Laurence DR; Stern GM; Armitage P
    Eur J Clin Pharmacol; 1971 Dec; 4(1):18-21. PubMed ID: 4948768
    [No Abstract]   [Full Text] [Related]  

  • 6. MK 486 and levodopa in treatment of Parkinsonism.
    Lieberman AN; Derby BM; Feigenson J; Goodgold A; Nesbitte J; Resurreccion EC; Valdivia F
    Dis Nerv Syst; 1973; 34(4):167-71. PubMed ID: 4711885
    [No Abstract]   [Full Text] [Related]  

  • 7. Levodopa in parkinsonism.
    Practitioner; 1972 May; 208(247):695-9. PubMed ID: 4560973
    [No Abstract]   [Full Text] [Related]  

  • 8. Levodopa therapy effects on natural history of Parkinsonism.
    Stern PH; McDowell F; Miller JM; Robinson MB
    Arch Neurol; 1972 Dec; 27(6):481-5. PubMed ID: 4628440
    [No Abstract]   [Full Text] [Related]  

  • 9. Injected apomorphine and orally administered levodopa in Parkinsonism.
    Düby SE; Cotzias GC; Papavasiliou PS; Lawrence WH
    Arch Neurol; 1972 Dec; 27(6):474-80. PubMed ID: 4563448
    [No Abstract]   [Full Text] [Related]  

  • 10. Ro 4-4602 and levodopa in the treatment of Parkinsonism.
    Miller EM; Wiener L
    Neurology; 1974 May; 24(5):482-6. PubMed ID: 4857107
    [No Abstract]   [Full Text] [Related]  

  • 11. Parkinsonism-dementia of Guam: treatment with levodopa and L-alpha-methyldopahydrazine.
    Holden EM; Brody JA; Chase TN
    Neurology; 1974 Mar; 24(3):263-5. PubMed ID: 4855953
    [No Abstract]   [Full Text] [Related]  

  • 12. Pyridoxine, DOPA, and Parkinsonism.
    Yahr MD; Duvoisin RC; Côté L; Cohen G
    Adv Biochem Psychopharmacol; 1972; 4():185-94. PubMed ID: 4555927
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term treatment of Parkinson's disease with levodopa.
    Martin WE; Loewenson RB; Bilek MK; Resch JA; Baker AB
    J Chronic Dis; 1974 Feb; 27(1):77-93. PubMed ID: 4815073
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of parkinsonism by amantadine and levodopa.
    Mawdsley C; Williams IR; Pullar IA; Davidson DL; Kinloch NE
    Clin Pharmacol Ther; 1972; 13(4):575-83. PubMed ID: 4557584
    [No Abstract]   [Full Text] [Related]  

  • 15. Status of the clinical evaluation of levodopa in the treatment of Parkinson's disease and syndrome.
    Langrall HM; Joseph C
    Clin Pharmacol Ther; 1971; 12(2):323-31. PubMed ID: 4930865
    [No Abstract]   [Full Text] [Related]  

  • 16. Sustained levodopa therapy in parkinsonism.
    Hunter KR; Shaw KM; Laurence DR; Stern GM
    Lancet; 1973 Oct; 2(7835):929-31. PubMed ID: 4126558
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma concentration of levodopa in patients with Parkinson's disease.
    Rinne UK; Sonninen V; Siirtola T
    Eur Neurol; 1973; 10(5):301-10. PubMed ID: 4789106
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhanced response to low doses of levodopa after withdrawal from chronic treatment.
    Sweet RD; Lee JE; Speigel HE; McDowell F
    Neurology; 1972 May; 22(5):520-5. PubMed ID: 4673448
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinical use of levodopa in the treatment of Parkinson's disease.
    McDowell FH; Markham CH; Lee JE; Treciokas LJ; Ansel RD
    Contemp Neurol Ser; 1971; 8():175-201. PubMed ID: 4950056
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of Parkinson's disease with Levodopa.
    Calhoun CL
    J Natl Med Assoc; 1972 Nov; 64(6):516-7 passim. PubMed ID: 4639943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.